Clinical Trials Browser

Lung Neoplasms × Diarylheptanoids × Thoracic × Clear all

NCT03598309 2026-02-27

Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

Phase 2 Active not recruiting

Lung Diseases, Lung Neoplasms